公开(公告)号：US20240363253A1

公开(公告)日：2024-10-31

申请号：US18630289

申请日：2024-04-09

申请人： Monitored Therapeutics, Inc.

发明人： Alex Stenzler ,  Mac Liaw ,  Martin Stegenga ,  Michael Taylor

IPC分类号： G16H50/30 ,  A61B5/00 ,  A61B5/0205 ,  A61B5/021 ,  A61B5/087 ,  A61B5/1455 ,  G16H10/20 ,  G16H10/60 ,  G16H20/10 ,  G16H80/00

CPC分类号： G16H50/30 ,  A61B5/0022 ,  A61B5/0205 ,  A61B5/744 ,  A61B5/746 ,  G16H10/20 ,  G16H10/60 ,  G16H20/10 ,  G16H80/00 ,  A61B5/021 ,  A61B5/0871 ,  A61B5/14551

摘要： A method for treating a patient with respiratory illness is described according to one embodiment. The method includes the steps of receiving a set of screening spirometry test data measured by a spirometer, generating a first patient performance score based on the received set of screening spirometry test data, generating one of a first high alert when the first patient performance score crosses a first threshold and a first low alert when the first patient performance score fails to cross the first threshold, receiving a set of at-home physiological test data, generating a second patient performance score based on the received set of at-home physiological test data, generating one of a second high alert when the second patient performance score crosses a second threshold and a second low alert when the second patient performance score fails to cross the second threshold, receiving a set of at-home patient survey data entered by the patient, generating a third patient performance score based on the received set of at-home patient survey data, and generating one of a third high alert when the third patient performance score crosses a third threshold and a third low alert when the third patient performance score fails to cross the third threshold.

公开(公告)号：US20240363228A1

公开(公告)日：2024-10-31

申请号：US18646018

申请日：2024-04-25

申请人： REMEPY HEALTH LTD

发明人： Amir AMEDI ,  Michal TSUR-SHALEV ,  Or SHOVAL ,  Shahar SHELLY ,  Nira Neomi SAPORTA

IPC分类号： G16H20/70 ,  A63F9/06 ,  G16H50/30

CPC分类号： G16H20/70 ,  A63F9/0612 ,  G16H50/30 ,  A63F2300/10 ,  A63F2300/30 ,  A63F2300/8094

摘要： The presently disclosed subject matter relates to computer-based methods in the field of digital therapeutics by means of a digital maze. The digital mazes utilize: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. Various digital interventions, their related methods in digital therapeutics and systems are disclosed herein.

公开(公告)号：US20240362866A1

公开(公告)日：2024-10-31

申请号：US18762194

申请日：2024-07-02

申请人： BOE TECHNOLOGY GROUP CO., LTD.

发明人： Bingdong WANG ,  Hua BAI ,  Yunan WANG ,  Limin YANG

IPC分类号： G06T19/00 ,  G06F3/04815 ,  G06F3/04845 ,  G06F3/0488 ,  G06T17/00 ,  G16H50/30

CPC分类号： G06T19/00 ,  G06F3/04815 ,  G06F3/04845 ,  G06T17/00 ,  G16H50/30 ,  G06F3/0488 ,  G06T2200/24 ,  G06T2210/41 ,  G06T2219/004

摘要： A health management system, including: a health assessment module configured to obtain human health-related health parameter information of a user, and generate a health condition assessment result on the basis of the health parameter information; a health intervention module configured to generate a health management plan on the basis of the health condition assessment result; a human body model generation module configured to generate a human body model that can be displayed on a display interface; and a human body information display model configured to: obtain at least one first display instruction each corresponding to one human body system model of a plurality of human body system models medically classified according to human body systems, and display, on the display interface, the three-dimensional human body model in the form of layers based on the human body system model corresponding to the at least one first display instruction.

公开(公告)号：US12131828B2

公开(公告)日：2024-10-29

申请号：US17314565

申请日：2021-05-07

申请人： Honeywell International Inc.

发明人： Adam Robert Gibson ,  Rajkumar Palanivel ,  Prabhat Ranjan ,  Kelvin Paul Towler ,  Kendall Paix ,  Mayur Sidram Salgar ,  Sheeladitya Karmakar ,  Manish Sharma

IPC分类号： G16H50/30 ,  G16H20/00 ,  G16H50/80

CPC分类号： G16H50/80 ,  G16H20/00 ,  G16H50/30

摘要： Devices, methods, and systems for monitoring and/or assessing compliance with infectious disease guidance for reducing infectious disease transmissions are described herein. The systems may include sensing devices at or within a facility and computing devices to compare data based on outputs from the sensing devices with guidance and/or recommendations for mitigating infectious disease transmission. Various compliance parameters may be identified as being relevant to the guidelines and measurable with outputs from the sensing devices. Various compliance parameters may be identified as being relevant to the guidelines, but not measurable with outputs from the sensing devices. The compliance parameters may be individually scored or scored in groups, including the compliance parameters not measureable with outputs from the sensing devices, and a score relative to a facility or group of facilities may be provided. The scores may be presented to via a dashboard.

公开(公告)号：US12130596B2

公开(公告)日：2024-10-29

申请号：US18076577

申请日：2022-12-07

申请人： Telesair, Inc.

发明人： Qing Wang ,  Yong Liu ,  Dongping Lin

IPC分类号： G05B13/02 ,  A61B5/00 ,  A61B5/08 ,  A61B5/1455 ,  G16H10/60 ,  G16H50/30 ,  H04N7/18

CPC分类号： G05B13/0265 ,  A61B5/0077 ,  A61B5/0816 ,  A61B5/14551 ,  A61B5/7221 ,  A61B5/743 ,  A61B5/746 ,  G16H10/60 ,  G16H50/30 ,  H04N7/183 ,  A61B2562/0204

摘要： A controlling method for monitoring a physiological condition of a first user. The method includes: obtaining first sensing data of the first user reported by at least one first sensing device; determining the physiological condition of the first user based on a result derived from the first sensing data and a reference range corresponding to the first sensing data; and upon determining that the physiological condition of the first user is abnormal, sending a control instruction to a second sensing device to switch the second sensing device from the first state to the second state.

公开(公告)号：US12130295B2

公开(公告)日：2024-10-29

申请号：US17508309

申请日：2021-10-22

申请人： LipoScience, Inc.

发明人： James D. Otvos ,  Irina Y. Shalaurova

IPC分类号： G01N33/92 ,  A61B5/00 ,  A61B5/055 ,  G01R33/465 ,  G16H10/40 ,  G16H50/30 ,  G16H50/50 ,  G16Z99/00 ,  G16B20/00 ,  G16C20/20

CPC分类号： G01N33/92 ,  A61B5/055 ,  A61B5/7275 ,  G01R33/465 ,  G16H10/40 ,  G16H50/30 ,  G16H50/50 ,  G16Z99/00 ,  G01N2800/32 ,  G16B20/00 ,  G16C20/20

摘要： Disclosed are methods and systems to determine a subject's metabolic vulnerability index (MVX) score using at least one defined mathematical model of risk. The methods comprise evaluating various biomarkers to distinguish various health risks. In one embodiment, the method comprises evaluating biomarkers to determine a relative risk of premature all-cause mortality. The model may include NMR-derived measurements of GlycA, S-HDLP, branched chain amino acids (BCAAs), ketone bodies, total serum protein, and citrate in at least one biosample of the subject.

公开(公告)号：US12128212B2

公开(公告)日：2024-10-29

申请号：US16973628

申请日：2019-06-19

申请人： PRESIDENT AND FELLOWS OF HARVARD COLLEGE

发明人： Eyal Dassau ,  Francis J. Doyle, III ,  Dawei Shi

IPC分类号： A61M5/172 ,  G16H10/60 ,  G16H20/17 ,  G16H40/40 ,  G16H40/67 ,  G16H50/20 ,  G16H50/30 ,  G16H70/40 ,  A61M5/142

CPC分类号： A61M5/1723 ,  G16H10/60 ,  G16H20/17 ,  G16H40/40 ,  G16H40/67 ,  G16H50/20 ,  G16H50/30 ,  G16H70/40 ,  A61M2005/14208 ,  A61M2230/201

摘要： A system for the delivery of insulin to a patient is provided. The systems and methods disclose include an insulin delivery device configured to deliver insulin to a patient in response to control signals. The system also includes a controller programmed to receive the sensor glucose measurement signal from the glucose sensor. The sensor glucose measurement signal received indicates a concentration of the real time glucose concentration in a bloodstream. The controller is further configured to enact an impeding glycemia protocol based on a zone model predictive control (MPC) algorithm in response to the real time glucose concentration. The impeding glycemia protocol includes in determining a relationship between predicted glucose concentrations, a rate of change of the predicted glucose concentrations, and a set of control parameters that determine insulin doses above and below a patient-specific basal rate.

公开(公告)号：US20240355481A1

公开(公告)日：2024-10-24

申请号：US18634898

申请日：2024-04-13

申请人： Amy Rosmarin ,  David R. Brown

发明人： Amy Rosmarin ,  David R. Brown

IPC分类号： G16H50/30 ,  G01W1/00

CPC分类号： G16H50/30 ,  G01W1/00

摘要： Described are systems and methods configured to accurately identify risk levels for individuals with varying sensitivities for those in close proximity to an emitting source and illustrates the impact of weather on levels of toxic concentration of airborne chemicals. As the methods and implementations described herein can be used for any location and any polluting point source of airborne chemicals, it can be a valuable tool to help residents in their efforts to reduce exposures and for medical providers to more accurately diagnose and treat exposed patients. For various distances from a polluting source, this methodology integrates weather, air dispersion analysis and emissions data of a single chemical or mixture of chemicals to provide a quantitative estimate of the frequency of unhealthy exposures to airborne toxins. Moreover, it specifies the frequency and past hours of unhealthy exposures according to the exposed person's sensitivity level.

公开(公告)号：US20240355480A1

公开(公告)日：2024-10-24

申请号：US18587367

申请日：2024-02-26

申请人： NEUMORA THERAPEUTICS, INC.

发明人： Yuelu LIU ,  Monika Sharma MELLEM ,  Parvez AHAMMAD ,  Humberto Andres GONZALEZ CABEZAS ,  Matthew KOLLADA

IPC分类号： G16H50/30 ,  A61B5/00 ,  A61B5/055 ,  A61B5/16 ,  G06F18/21 ,  G06F18/214 ,  G06N20/00 ,  G16H10/20 ,  G16H20/70 ,  G16H30/20 ,  G16H30/40 ,  G16H50/20 ,  G16H50/70

CPC分类号： G16H50/30 ,  A61B5/0042 ,  A61B5/055 ,  A61B5/16 ,  A61B5/7267 ,  G06F18/2148 ,  G06F18/2178 ,  G06F18/2193 ,  G06N20/00 ,  G16H10/20 ,  G16H30/20 ,  G16H30/40 ,  G16H50/20 ,  G16H50/70 ,  A61B2576/026 ,  G06V2201/031 ,  G16H20/70

摘要： A system for evaluating mental health of patients includes a memory and a control system. The memory contains executable code storing instructions for performing a method. The control system is coupled to the memory and includes one or more processors. The control system is configured to execute the machine executable code to cause the control system to perform the method: A selection of answers associated with a patient is received. The selection of answers corresponds to each question in a series of questions from mental health questionnaires. Unprocessed MRI data are received. The unprocessed MRI data correspond to a set of MRI images of a biological structure associated with the patient. The unprocessed MRI data is processed to output a set of MRI features. Using a machine learning model, the selection of answers and the set of MRI features are processed to output a mental health indication of the patient.

公开(公告)号：US20240355479A1

公开(公告)日：2024-10-24

申请号：US18580973

申请日：2022-01-24

申请人： HITACHI HIGH-TECH CORPORATION

发明人： Hiromitsu NAKAGAWA ,  Takeshi TANAKA ,  Daisuke FUKUI

IPC分类号： G16H50/30 ,  G06T7/00 ,  G06T7/70 ,  G06V40/20 ,  G16H30/40

CPC分类号： G16H50/30 ,  G06T7/0016 ,  G06T7/70 ,  G06V40/25 ,  G16H30/40 ,  G06T2207/20081 ,  G06V2201/033

摘要： A measurement apparatus includes: a measurement data acquisition unit configured to acquire measurement data of a target; and a processing unit configured to process the measurement data. The processing unit estimates a skeleton of a living body that is the target based on the measurement data, estimates a measurement condition related to the measurement data using an estimation result of the skeleton, obtains a similarity between the measurement condition and an assumed condition assumed in advance, and selects measurement data related to evaluation of a state of the target based on the similarity. With the configuration and operations,, it is possible to efficiently collect data related to evaluation of a state of a target while considering a restriction of a location where measurement data is acquired, without collecting a large amount of data.